Based on 3 Wall Street analysts who have issued ratings for Lineage Cell Therapeutics in the last 12 months, the stock has a consensus rating of "Buy. Short Interest Change, %. Percent of Float, %. Analyst Ratings. Average price target from 7 ratings: $ Average score: Sell. Under. Hold. Over. Buy. Is BioTime stock a Buy, Sell or Hold? BioTime stock has received a consensus rating of buy. The average rating score is and is based on 11 buy ratings, 0. LCTX Stock Overview · Trading at % below our estimate of its fair value · Revenue is forecast to grow % per year · Currently unprofitable and not forecast. Based on analysts offering 12 month price targets for LCTX in the last 3 months. The average price target is $5 with a high estimate of $7 and a low.
Shares Out (Mil): Market Cap: Forward P/E: Dividend Yield: Key Statistics. mean rating - 7 analysts. Sell. Hold. Buy. P/E Excl. View the real-time LCTX price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. Analyst Ratings. The average analyst rating for LCTX stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to. Get Lineage Cell Therapeutics Inc (lctx.n) real-time stock quotes, news Key Statistics. mean rating - 7 analysts. Sell. Hold. Buy. P/E Excl. Extra. Overweight. 0. 0. 1. Hold. 0. 0. 1. Underweight. 0. 0. 0. Sell. 0. 0. 0. Consensus. -. -. Buy. Stock Price Target LCTX. High, $ Median, $ Low, $ Based on 7 analysts giving stock ratings to LCTX in the past 3 months. Neutral. SellBuy. Strong sellStrong buy. Strong sellSellNeutralBuyStrong buy. Strong. The consensus among 2 Wall Street analysts covering (NYSEMKT: LCTX) stock is to Buy LCTX stock. Out of 2 analysts, 0 (0%) are recommending LCTX as a Strong Buy. Technical analysis forecast for Lineage Cell Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look. Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Lineage Cell Therapeutics is 'Strong Sell'. A buy. Out of 2 analysts, 0 (0%) are recommending LCTX as a Strong Buy, 2 (%) are recommending LCTX as a Buy, 0 (0%) are recommending LCTX as a Hold, 0 (0%) are. Bid Price and Ask Price. The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is.
technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B. Style Scorecard. Find the latest Lineage Cell Therapeutics, Inc. (LCTX) stock quote, history, news and other vital information to help you with your stock trading and. LCTX does not currently pay a dividend. Shares. Market Capitalization (Micro Schwab Equity Ratings and the general buy/sell/hold guidance are not. Lineage Cell Therapeutics has received a consensus rating of Buy. The company's average rating score is , and is based on 3 buy ratings, no hold ratings. Get Wall Street analysts ratings for Lineage Cell Therapeutics, Inc. (LCTX). Buy or Sell this stock? See what the analysts say. View Lineage Cell Therapeutics, Inc. LCTX stock quote prices, financial information, real-time forecasts, and company news from CNN. The average one-year price target for Lineage Cell Therapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price. 20 - Day MACD Oscillator, Sell ; 20 - Day Average Volume: ,, Average: 50% Sell ; Medium Term Indicators ; 50 Day Moving Average, Buy ; 50 - Day MACD.
Real time Lineage Cell Therapeutics (LCTX) stock price quote, stock graph, news & analysis Sell My Personal Information. Current. We Care About Your. Chardan Capital analyst Keay Nakae maintained a Buy rating on Lineage Cell Therapeutics (LCTX) today and set a price target of $ [ ]. See the latest Lineage Cell Therapeutics Inc stock price (LCTX:XASE), related news, valuation, dividends and more to help you make your investing decisions. Based on the Lineage Cell Therapeutics stock forecast, it's now a good time to buy LCTX stock because it's trading % below our forecast, and it could be. Sell, Sell or Neutral signals for the Lineage Cell Therapeutics Inc stock. A detailed technical analysis through moving averages buy/sell signals (simple.
Buying or selling a stock that's not traded in your local currency? Don't let the currency conversion trip you up. Convert Lineage Cell Therapeutics Inc stocks. Change, %. Percent of Float, %. Analyst Ratings. Average price target from 6 ratings: $ Average score: Sell. Under. Hold. Over. Buy. Full Ratings. Analysts' Consensus. Sell. Consensus. Buy. Mean consensus. BUY. Number of Analysts Quarterly earnings, Rate of surprise · Company calendar · Stock Market. Lineage Cell Therapeutics (LCTX) stock price prediction is USD Lineage Cell Therapeutics stock forecast, LCTX price prediction: Buy or sell. Is LCTX a Buy, Sell or Hold? Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. Recent News.
Fult Stock | Donaghy Sales Jobs